You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic head and neck cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +5 more
  • IK-175 + nivolumab
  • Chicago, Illinois
  • +3 more
Jul 26, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Carboplatin)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Nov 1, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Spine
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • e-PRO monitoring
  • Kobe, Hyogo, Japan
    Kobe University Graduate School
Jun 27, 2023

Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)

Terminated
Has Results
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Omaha, Nebraska
  • +3 more
Dec 16, 2022

Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)

Active, not recruiting
  • Head and Neck Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Jan 31, 2023

Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma Trial in China (TQB2618 injection,

Not yet recruiting
  • Recurrent Squamous Cell Carcinoma of the Head and Neck
  • Metastatic Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
  • Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
  • Lanzhou, Gansu, China
  • +11 more
Mar 23, 2023

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Head Neck Cancer Trial in Tyler (Buparlisib & Paclitaxel)

Recruiting
  • Head and Neck Cancer
  • Buparlisib & Paclitaxel
  • Tyler, Texas
    Hope Cancer Center, UT Health East Texas
Aug 11, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +3 more
  • 200 mg Pembrolizumab
  • +2 more
  • Miami, Florida
  • +6 more
Jan 9, 2023

Proton SBRT and Immunotherapy for Recurrent/Progressive

Terminated
  • Head and Neck Cancer
  • Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Aug 31, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Head and Neck Squamous Cell Carcinoma Trial in Buffalo (Palliative Therapy, Quality-of-Life Assessment, Questionnaire

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Palliative Therapy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 26, 2022

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Head and Neck Tumors Trial (Pembrolizumab, Carboplatin, Paclitaxel)

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • (no location specified)
Jun 13, 2022

Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell

Withdrawn
  • Multiple Indications Cancer
  • Non-Interventional
  • Mexico, Distrito Federal, Mexico
    Local Institution
May 25, 2022

Head-and-neck Squamous Cell Carcinoma Trial in San Francisco (89Zr-panitumumab IV, Panitumumab)

Not yet recruiting
  • Head-and-neck Squamous Cell Carcinoma
  • San Francisco, California
    Stanford Cancer Institute
Jun 14, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Nivolumab 480mg and surgical resection
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Feb 25, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Not yet recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • (no location specified)
Jan 31, 2023

Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

Not yet recruiting
  • Melanoma
  • +5 more
  • RC198 Injection
  • Auchenflower, Queensland, Australia
    Research Site
May 17, 2023

Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, Hypopharyngeal Carcinoma Trial in Scottsdale, Rochester

Recruiting
  • Head and Neck Carcinoma
  • +10 more
  • Scottsdale, Arizona
  • +1 more
Jan 6, 2023

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Trial (NRC-2694-A, Paclitaxel)

Recruiting
  • Carcinoma
  • Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
  • Los Angeles, California
  • +2 more
Nov 23, 2022

NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 29, 2023